Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2013
11/14/2013US20130302313 Hexon tat-ptd modified adenovirus and uses thereof
11/14/2013US20130302288 Modalities for the treatment of degenerative diseases of the retina
11/14/2013US20130302286 Modalities for the treatment of degenerative diseases of the retina
11/13/2013EP2661494A2 Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
11/13/2013EP2661489A2 Methods for enhancing the delivery of gene-transduced cells
11/13/2013EP2661454A1 Cationic polymers formed from amino group-bearing monomers and heterocyclic linkers
11/13/2013CN103387952A New application of gamma-secretase inhibitor and method for improving susceptibility of eukaryotic cells to coxsackie virus B (CVB)
11/13/2013CN103386138A MicroRNA regulating cilium development, and application thereof
11/13/2013CN103386137A New application of Notch intracellular domain(NICD) gene and method and drugs for improving ability of eukaryotic cells in resisting coxsachie virus B (CVB) infection
11/13/2013CN103386119A Application of SIRT1 in adjusting rhythm and improving rhythm disorder
11/13/2013CN102649963B Human papillomavirus (HPV) L1-based recombinant adenovirus for preventing and treating esophagus cancer
11/13/2013CN102512694B Biological preparation for resisting against replication and infection of foot-and-mouth disease virus and preparation method as well as application thereof
11/13/2013CN102475893B Method for treating human malignant solid tumor by using hepatocyte nuclear factor-1alpha
11/13/2013CN102329810B siRNA conveying carrier and application thereof
11/13/2013CN102070710B Specific GRA2a (Glycine Rich Antigen)-type antigenic protein of clonorchis sinensis and application thereof
11/13/2013CN101921292B Novel siRNA chemical modification monomer, preparation method thereof and use thereof
11/12/2013US8580941 Epididymal lipocalin gene and uses thereof
11/12/2013US8580761 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
11/12/2013US8580758 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method
11/12/2013US8580757 Methods of modulating mesenchymal stem cell differentiation
11/12/2013US8580755 Methods and compositions for treating inflammatory conditions
11/12/2013US8580743 Modified galectin 9 proteins and methods of treatment using them
11/12/2013US8580563 Placental stem cells
11/12/2013US8580275 Drug delivery product and methods
11/12/2013US8580249 Cell therapy for the treatment of lysosomal storage disorders
11/12/2013CA2714357C Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
11/12/2013CA2471924C Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
11/12/2013CA2342376C A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
11/12/2013CA2340673C Method for detection of biological factors in epidermis
11/12/2013CA2213451C Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
11/07/2013WO2013166470A2 Uses of cxcl17, a novel chemokine marker of human lung and gastrointestinal disease
11/07/2013WO2013166264A2 Methods for altering virus replication
11/07/2013WO2013166156A2 Compositions and methods for treating or preventing osteoarthritis
11/07/2013WO2013166000A1 Modulating immune responses
11/07/2013WO2013165816A2 SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
11/07/2013WO2013164793A2 Viral vectors for the treatment of retinal dystrophy
11/07/2013WO2013163893A1 Modified bacteria and uses thereof for treatment of cancer or tumor
11/07/2013WO2002083860A9 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
11/07/2013US20130296404 Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same
11/07/2013US20130296246 Composition
11/07/2013US20130296179 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
11/07/2013US20130295615 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
11/07/2013US20130295160 Antagonists of mir-196a
11/07/2013US20130295159 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
11/07/2013US20130295139 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
11/07/2013US20130295128 Chimeric vaccines
11/06/2013EP2660335A2 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical microorgamisms from clinical specimens for diagnosis
11/06/2013EP2660325A2 AAV vectors and corresponding nucleotide sequences and methods
11/06/2013EP2660322A2 Modified iRNA agents
11/06/2013EP2659910A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells
11/06/2013EP2658982A1 Small molecule conjugates for intracellular delivery of biologically active compounds
11/06/2013EP2658981A1 Small molecule conjugates for intracellular delivery of nucleic acids
11/06/2013EP2658973A2 siRNA FOR INHIBITION OF Hif1alpha EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME
11/06/2013EP2658579A2 In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
11/06/2013EP2359853B1 Pharmaceutical compositions and methods useful for modulating angiogenesis
11/06/2013EP2284266B1 siRNA targeting tp53
11/06/2013CN103382472A New targets for interference of EV71, small interfering RNAs and application thereof
11/06/2013CN103382220A Cell factor FAM19A4 with anti-infection and antineoplastic activity and application thereof
11/06/2013CN103382218A Cell-penetrating peptide and pharmaceutical composition and preparation method and application thereof
11/06/2013CN103382217A Cell-penetrating peptide and pharmaceutical composition and preparation method and application thereof
11/06/2013CN103381274A Genetic products differentially expressed in tumors and the use thereof
11/06/2013CN102772797B Genetic engineering polypeptide vaccine for 4 subtypes of O-type foot and mouth disease virus and its application
11/06/2013CN102743763B Drug for treating glaucoma
11/06/2013CN102732519B Screening and application of special siRNA of multi-serotype foot and mouth disease virus 3C gene
11/06/2013CN102504015B Cardiovascular targeted small peptide MI-1 and application thereof
11/06/2013CN102399780B Interfering RNA (Ribonucleic Acid) for suppressing hand-foot-and-mouth disease virogene, vector containing the same and application thereof
11/06/2013CN102336802B Glycyrrhetinic acid-modified lipid, liver targeting liposome, micelle and compound, and their preparation method
11/06/2013CN102206275B Anti-tetanotoxin monoclonal neutral antibody, and composition and application thereof
11/06/2013CN102036690B Novel soluble CD83 polypeptides, formulations and methods of use
11/06/2013CN101864400B Specific recombinant adenoviruses, preparation thereof and use thereof
11/06/2013CN101628111B Taci-immunoglobulin fusion proteins
11/05/2013US8575125 Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
11/05/2013US8575123 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
11/05/2013US8574900 Nucleic acid silencing sequences
11/05/2013US8574564 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
11/05/2013CA2529103C Use of a recombinant vector encoding il-10 for treating neuropathic pain
11/05/2013CA2467936C Method of inhibiting gene expression
11/05/2013CA2461176C Treatment of central nervous system disorders by use of pdgf or vegf
11/05/2013CA2394015C Tweak receptor
11/05/2013CA2364417C Peroral gene therapy of diabetes and obesity
11/05/2013CA2328403C Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
10/2013
10/31/2013WO2013163628A2 Genetic correction of mutated genes
10/31/2013WO2013163404A1 TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
10/31/2013WO2013163303A2 Transferrin receptor aptamers and aptamer-targeted delivery
10/31/2013WO2013163296A1 Generating pluripotent cells de novo
10/31/2013WO2013162350A2 Circular antiviral rna
10/31/2013WO2013162054A1 Composition for controlling chromatin structure
10/31/2013WO2013162027A1 Neuronal differentiation promoter
10/31/2013WO2003023014A9 Human ion channels
10/31/2013WO2002098346A3 Method and pharmaceutical composition for the treatment of multiple sclerosis
10/31/2013WO2002094993A9 Kin28 polynucleotides and polypeptides and uses thereof
10/31/2013US20130287785 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
10/31/2013US20130287738 Disease-associated protein
10/30/2013EP2657353A1 Ultraconserved regions encoding ncRNAs
10/30/2013EP2657342A1 DNA dendrimers protected against nuclease degradation are useful as vectors for the delivery of siRNA
10/30/2013EP2657339A2 Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence
10/30/2013EP2656858A1 Transpulmonary liposome for controlling drug arrival
10/30/2013EP2656837A1 Lipid nanoparticles for treating ocular diseases
10/30/2013EP2656833A1 Crosslinked Hyaluronic Acid Compositions For Tissue Augmentation
10/30/2013EP2654801A1 Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 870